Oxacillin

Generic Name
Oxacillin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H19N3O5S
CAS Number
66-79-5
Unique Ingredient Identifier
UH95VD7V76
Background

An antibiotic similar to flucloxacillin used in resistant staphylococci infections.

Indication

Used in the treatment of resistant staphylococci infections.

Associated Conditions
Catheter Related Infections, Community Acquired Pneumonia (CAP), Infections caused by penicillinase-producing staphylococci, Necrotizing Soft Tissue Infections, Surgical Site Infections
Associated Therapies
-
Clinical Trials
Related News

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

First Posted Date
2021-03-01
Last Posted Date
2024-12-10
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
200
Registration Number
NCT04775953
Locations
🇺🇸

Corewell Health - Infectious Disease, Royal Oak, Michigan, United States

🇺🇸

University of Alabama Hospital - Infectious Diseases, Birmingham, Alabama, United States

🇺🇸

University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States

and more 21 locations

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

First Posted Date
2016-06-28
Last Posted Date
2024-01-17
Lead Sponsor
AbbVie
Target Recruit Count
199
Registration Number
NCT02814916
Locations
🇱🇹

Klaipeda Children's Hospital /ID# 235652, Klaipeda, Lithuania

🇧🇬

University Multiprofile Hospital for Active Treatment Deva Maria EOOD Burgas /ID# 235965, Bulgas, Bulgaria

🇧🇬

MHAT (Multiprofile Hospital for Active Treatment) /ID# 235539, Kozloduy, Bulgaria

and more 81 locations

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

First Posted Date
2007-01-30
Last Posted Date
2018-01-31
Lead Sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Target Recruit Count
75
Registration Number
NCT00428844
Locations
🇺🇸

Dartmouth-Hitchcock Medical center, Lebanon, New Hampshire, United States

🇷🇺

Federal Healthcare Institute "Novosibirsk Scientific Research Institute of Traumatology and Orthopedy Rosmeditechnology", Novosibirsk, Russian Federation

🇺🇸

Gundersen Clinic, LTD, La Crosse, Wisconsin, United States

and more 23 locations

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

First Posted Date
2002-05-15
Last Posted Date
2009-09-14
Lead Sponsor
Pfizer
Target Recruit Count
739
Registration Number
NCT00037050
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy